October 31, 2011
Japan Tobacco (JT) announced on October 28 that a new drug application (NDA) for a combination tablet containing the anti-HIV drug JTK-303 (elvitegravir) was filed in the US by its licensee Gilead Sciences of the US. The combination tablet contains...read more